Results 241 to 250 of about 321,570 (302)

Therapeutic Impact of GLP‐1 Receptor Agonists on Parkinson's Disease: A Scoping Review

Neurology and Clinical Neuroscience, EarlyView.
ABSTRACT No disease‐modifying treatment exists for Parkinson's disease (PD). Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have gained attention as promising candidates for neuroprotection, given documented expression of GLP‐1 receptors within the central nervous system and the contribution of brain insulin resistance to dopaminergic ...
João Pedro Henriques, João Pedro Stringhetta Rahal, Rafael da Cunha Gomes Ribeiro, Enzo Bogucheski Ribeiro Machado, Carlos Antonio Negrato   +4 more
wiley   +1 more source

Granisetron for Postoperative Nausea and Vomiting Prophylaxis in Microvascular Decompression Despite Prominent Non-serotonergic Emetic Pathways. [PDF]

Cureus
Oishi H, Kato T, Hagiwara N, Hasegawa T.
europepmc   +1 more source

Evaluation of food safety in the handling of home enteral nutrition based on a new contamination risk classification: A cross‐sectional study

Nutrition in Clinical Practice, EarlyView.
Abstract Background Home enteral nutrition (HEN) offers clinical benefits and is increasingly used, although handling‐related health risks remain unclear. This study assessed food safety in HEN using a new contamination risk classification. Methods First, the inter‐rater reliability of the Food Safety for Handling HEN checklist was analyzed in 25 ...
Elaine Cristine de Souza Martins, Caroline Opolski Medeiros, Rayane Luizi da Costa, Luciana Karbiak, Márcia Regina Beux, Diego Averaldo Guiguet Leal, Lize Stangarlin‐Fiori   +6 more
wiley   +1 more source

Progress in traditional Chinese medicine for chemotherapy-induced nausea and vomiting, based on the theory of "Fuzheng Quxie" and "Hewei Jiangni". [PDF]

Am J Transl Res
Zhu L, Zhao Y, Gao Q, Liu X, Chen F, Li L, Fu Y.   +6 more
europepmc   +1 more source

Endoscopic small bowel therapies for type 2 diabetes

Nutrition in Clinical Practice, EarlyView.
Abstract Type 2 diabetes is a global epidemic despite current medical treatments. Many patients are not responsive to medications, and patients with obesity are hesitant about bariatric surgery. Studies investigating the metabolic effects of Roux‐en‐Y gastric bypass have increasingly demonstrated that the duodenum plays a key role in the ...
Roma Patel, Zehra Naseem, Prisha Gattu, Stephen Firkins, Roberto Simons‐Linares   +4 more
wiley   +1 more source

The Role of Gut Microbiota and Their Derived Metabolites in Chemotherapy-Induced Nausea and Vomiting in Ovarian Cancer. [PDF]

Cancer Med
Zu S, Yu X, Song J, Xiao Y, Yi H, Li H.
europepmc   +1 more source

Effect of GLP‐1 receptor agonist on nutrient intake: A narrative review

Nutrition in Clinical Practice, EarlyView.
Abstract Humans have a primitive defense mechanism called metabolic adaptation that slows voluntary weight loss. It works by downregulating hormones that reduce food intake and by lowering the metabolic rate. Second‐generation GLP‐1 receptor agonists, such as semaglutide or tirzepatide, promote weight loss by targeting this hormonal system to control ...
Ken Fujioka
wiley   +1 more source

Perioperative predictors of prolonged hospital stay and postoperative nausea and vomiting after metabolic bariatric surgery. [PDF]

BMC Anesthesiol
Lee TY, Lu CH, Lai CW, Illias AM, Wu SC, Liu YF, Tsai YF.   +6 more
europepmc   +1 more source

Complications of Cochlear Implant Surgery in Low‐ and Middle‐Income Countries: A Systematic Review

Otolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective Hearing loss disproportionately affects low‐ and middle‐income countries (LMICs). Recent advances in cochlear implant surgery have benefitted patients globally, but the risk of complications in LMICs may be heightened due to social and structural factors.
Akash Srinivasan, Anavi Prakash, Wing K. Chou, Kat Steiner, Kokila Lakhoo   +4 more
wiley   +1 more source

Glycopyrronium Bromide versus Droperidol for Prophylaxis of Postoperative Nausea and Vomiting in Hysteroscopic Day Surgery: A Randomized, Double-Blind, Non-Inferiority Trial. [PDF]

Drug Des Devel Ther
Wang X, Sun N, Xiao M, Chen Z, Yang X, Ren H, Ji F, Xiao H.   +7 more
europepmc   +1 more source